American pharmaceutical company Nova Vaccine claims that its Corona vaccine is 90% effective
American pharmaceutical company NovaVix claims that its Corona vaccine is 90% effective.
According to NovaVix, in the third phase of the clinical trial, his vaccine was able to provide 100% protection in Corona cases.
Novavix plans to apply for Food and Drug Administration (FDA) approval in the third quarter of this year.
The pharmaceutical company claims that the vaccine was 93% successful against other disturbing forms of corona.
Only 1% reported mild to moderate pain at the injection site after the vaccine, which subsided in less than 3 days.
According to the American company, the third phase of the clinical trial involved 30,000 people aged 18 and over from the United States and Mexico.
On the other hand, reports say that the American pharmaceutical company has not submitted any product for approval in the United States in 33 years.